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Abstract: As the global incidences of colorectal cancer rises, there is a growing importance in
understanding the interaction between external factors, such as common infections, on the initiation
and progression of this disease. While certain helminth infections have been shown to alter the
severity and risk of developing colitis-associated colorectal cancer, whether these parasites can directly
affect colorectal cancer progression is unknown. Here, we made use of murine and human colorectal
cancer cell lines to demonstrate that exposure to antigens derived from the gastrointestinal nematode
Heligmosomoides polygyrus significantly reduced colorectal cancer cell proliferation in vitro. Using a
range of approaches, we demonstrate that antigen-dependent reductions in cancer cell proliferation
and viability are associated with increased expression of the critical cell cycle regulators p53 and
p21. Interestingly, H. polygyrus-derived antigens significantly increased murine colorectal cancer
cell migration, which was associated with an increased expression of the adherens junction protein
β-catenin, whereas the opposite was true for human colorectal cancer cells. Together, these findings
demonstrate that antigens derived from a gastrointestinal nematode can significantly alter colorectal
cancer cell behavior. Further in-depth analysis may reveal novel candidates for targeting and treating
late-stage cancer.
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1. Introduction
Globally, colorectal cancer (CRC) is the third most commonly diagnosed malignancy and the
second leading cause of cancer deaths [1]. In 2018 alone, CRC represented 1.8 million new worldwide
cancer cases and 900,000 deaths. It has been suggested that the lifestyle that is common in more
developed countries, including a diet low in fiber, fruits, and vegetables, obesity, lack of physical
activity, excessive alcohol consumption, and a lack of sleep, increases the risk of developing CRC [2,3].
Furthermore, chronic inflammation associated with inflammatory bowel disease (IBD) has been linked
to an increased risk of high-grade dysplasia and cancer, known as colitis-associated colorectal cancer
(CAC) [4,5].
Notably, many soil-transmitted helminths (STH) establish life-long infections associated with
chronic inflammation within the gastrointestinal tract. During persistent infection, parasitic helminths
release excretory/secretory products containing components that can modify systemic and local
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inflammatory responses [6]. Both helminth infections and their associated antigens have been shown
to alter the development and progression of CAC [7–11]. Despite this, it is unclear whether these
parasites can directly impact CRC progression. Helminths infect over 1 billion individuals in low- and
middle-income countries and result in the loss of 20 million disability-adjusted life years (the amount
of years lost due to illnesses, disability, or premature death) [12,13]. The gastrointestinal tract of an
individual living in these regions is likely to be parasitized by one, if not all three, of the leading
STH: roundworms, hookworms, and whipworms [14]. Globally, 807 million people are infected
with roundworms, 700 million are infected with hookworms and 604 million are infected with
whipworms [14].
Certain helminth infections have been shown to confer an advantage to the host, by reducing
autoimmune and allergic symptoms in infected individuals [15–18]. However, others have been
reported to diminish vaccine efficacy and impair host immune responses to co-infection [19–21].
Moreover, although only partially understood, helminth infections can also influence the risk of cancer
development. For example, Opisthorchis viverrini and Clonorchis sinensis are classified as group one
biological carcinogens and are conclusive causes of cholangiocarcinoma (CCA), also known as bile
duct cancer [22,23]. Opisthorchis-induced CCA is thought to occur due to damage to the bile duct
epithelium, cell proliferation, and inhibition of DNA repair and apoptosis, which are a consequence of
mechanical damage caused by feeding parasites, immunopathology and the effects of fluke secreted
proteins [24].
Chronic infection with Schistosoma has been associated with the development of bladder cancer,
increased chromosomal aberrations, and increased DNA copy number [25,26]. Increased CRC was
also observed in patients with a chronic Schistosoma or gastrointestinal parasitic infection [27,28].
Accumulating evidence in pre-clinical murine models of CRC suggests that differing STH infections
can have diverse effects on CRC initiation by exacerbating neoplastic change and tumor formation or
inducing intestinal epithelial cell remodeling [29,30]. Although increased CRC following Schistosoma
infection has been associated with the deposition of Schistosomal ova, which has been shown to contain
oncogenic antigens, it is not currently known how STH antigens influence CRC progression [31,32].
Here, we made use of antigen derived from Schistosoma mansoni and Heligmosomoides polygyrus to
determine how STH antigens impact CRC cell proliferation and migration. We reveal that antigen
derived from H. polygyrus significantly decreased murine and human CRC cell proliferation, which was
associated with increased expression of p53 and p21. Furthermore, exposure to these antigens reduced
both murine and human CRC cell mitochondrial activity. H. polygyrus-derived antigens increased
murine CRC cell migration, which was associated with increased expression of the adherens junction
protein β-catenin. Interestingly, the opposite was true for human colorectal cancer cells. These data
demonstrate the usefulness of in vitro assays in assessing how differing parasite antigens impact
on CRC cell behavior and identify pathways that are altered in CRC cells following exposure to
helminth antigens.
2. Results
2.1. H. polygyrus-Derived Antigens Limit CRC Cell Proliferation and DNA Synthesis
Presently, the effect of exposure to STH antigens on CRC cell proliferation is not known.
We therefore exposed murine CT26.WT CRC cells to 10 µg antigen from H. polygyrus adults and
the excretory/secretory products (HES) and quantified the impact on cell viability using trypan
blue exclusion. Our results reveal that, compared to untreated cells, there was a significantly
decreased number of viable treated CT26.WT cells (Figure 1a). To confirm the results seen in Figure 1a,
a BrdU incorporation assay was performed, which quantifies DNA synthesis in replicating (cycling)
cells. The results demonstrated that, while HES treatment significantly reduced DNA synthesis in
CT26.WT cells, there was no significant effect observed for H. polygyrus antigen treatment (Figure 1b,c).
Surprisingly, increasing doses of the egg antigen derived from Schistosoma mansoni ova (SEA) had no
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effect on CT26.WT cell proliferation (Figure 1d). We then confirmed that 10 µg of HES significantly
decreased the number of viable human CRC cells and limited human CRC cell proliferation using the
cell line HCT116 (Figure 1e). With this cell line, no significant effect on proliferation was observed for
H. polygyrus antigen treatment (Figure 1e).
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2.2. H. polygyrus Excretory/Secretory Products Significantly Decrease CRC Cell Viability in a
Species-Specific Manner
Cell proliferation is defined as a balance between cell division and cellular differentiation
or cell death. In order to further determine the factors contributing to the significant reduction
in cell proliferation and DNA synthesis seen in Figure 1a–d, an 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay was performed to quantify the mitochondrial activity as a
measure of cell viability. Consistent with the BrdU results, incubation with HES significantly reduced
the cell viability in murine CT26.WT cells. However, no significant effect was observed for H. polygyrus
antigen treatment (Figure 2a), nor for treatment of human HCT116 CRC cells with HES (Figure 2b).
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Figure 2. H. polygyrus-derived a tigens decrease colorect l ancer ( RC) cell viability. The cell viability
of (a) CT26.WT and (b) HCT116 cells exposed t 10 µg HES r 10 µg H. polygyrus antigen for 48 h
was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. MTT was
added to each well for 4 h, followed by the addition of the solubilizer, and 24 h later, the absorbance
of each well was read at a wavelength of 595 nm. The data are representative of three independent
experiments. Significance was analysed using GraphPad Prism 6.01 and a one-way ANOVA was
performed, where * p < 0.05 and ** p < 0.01. Error bars represent the standard error of the mean.
2.3. H. polygyrus-Derived Antigens Increase the Expression of the Cell-Cycle Arrest Proteins p21 and p53 in
CRC Cells
In response to cellular stress, the tumor suppressor p53 is activated and, in order to prevent the
proliferation of damaged cells, it transactivates its target genes that control cell-cycle arrest, senescence,
and/or apoptosis [33]. Targets of p53 include p21, a cyclin-dependent kinase inhibitor, which induces
cell-cycle arrest [34]. Given the impact of H. polygyrus-derived antigens on the proliferation of human
and murine cells lines (Figure 1a or Figure 1e), we next examined whether this activity was related to
changes in p53 and p21. Results from two independent experiments demonstrate that both H. polygyrus
antigen and HES elevated the expression of p53 and p21 in murine CT26.WT (Figure 3a) and in human
HCT116 (Figure 3b) cells (Supplementary Materials, Figure S1). In CT26.WT cells, HES and H. polygyrus
antigen increased the expression of p53 at 12 h (mean 183.65 fold, SD 247.8, and mean 105.85 fold,
SD 137.2, respectively) and at 18 h (mean 1.5 fold, SD 0, and mean 2.45 fold, SD 1.2, respectively)
(Figure 3a top panel; Supplementary Materials: Figure S1a top panel). The expression of p21 was
also increased following exposure to HES and H. polygyrus antigen at 12 h (mean 7.15 fold, SD 0.4,
and mean 9.35 fold, SD 5.2, respectively) and at 18 h (mean 5.55 fold, SD 6.3, and mean 8.2 fold, SD 9.6,
respectively) (Figure 3a middle panel; Supplementary Materials: Figure S1a middle panel). In HCT116
cells, HES and H. polygyrus antigen increased the expression of p53 at 24 h (mean 26.8 fold, SD 34.2,
and mean 95.3 fold, SD 5.8, respectively) and at 30 h (mean 1.8 fold, SD 0.9, and mean 2.4 fold, SD 0.6,
respectively) (Figure 3b top panel; Supplementary Materials: Figure S1b top panel). The expression
of p21 was increased by HES and H. polygyrus antigen at 24 h (mean 95.7 fold, SD 132.7, and mean
57.35 fold, SD 78.4, respectively) and at 30 h (mean 28.65 fold, SD 38.5, and mean 16.05 fold, SD 18.9,
respectively (Figure 3b middle panel; Supplementary Materials: Figure S1b third panel).
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Figure 3. H. polygyrus-derived antigens increase the expression of colorectal cancer (CRC) cell-cycle
arrest proteins p53 and p21. Western blot analyses of p53, p21, and p38 (loading control) were performed
following exposure of (a) CT26.WT cells for 12- and 18-h and (b) HCT116 cells for 24- and 30-h to
10 µg HES or 10 µg H. polygyrus antigen. Densitometry readings were obtained using ImageJ in order
to determine the changes in protein expression of p53 and p21 normalized to p38 and expressed as
a fold-change relative to control wells. The data is representative of two independent experiments.
2.4. H. polygyrus-Derived Antigens Increase Murine CRC Cell Migration and β-Catenin Expression
Cell migration is a fundamental step in CRC progression and is associated with poor outcome.
We therefore next assessed whether the H. polygyrus-derived antigens would alter CRC cell migration
using a transwell migration assay. We demonstrate that H. polygyrus antigen significantly increased
CT26.WT cell migration, whereas there was a trend toward increased migration following exposure to
HES (Figure 4a). The aberrant expression and accumulation of β-catenin is a signature of CRC cell
patients [35]. This dual function protein, involved in cell-cell adhesion and transcription, is thought
to promote invasion, metastasis, and dormancy in human colorectal tumors [36]. Results from one
western blot experiment suggest that increased CT26.WT cell migration, following treatment with
H. polygyrus-derived antigens, was associated with increased expression of β-catenin (Figure 4b).
The expression of β-catenin was increased by HES and H. polygyrus antigen at 12 h by 2.41 and 2.11-fold,
respectively, and at 18 h by 1.69 and 1.14-fold, respectively.
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Figure 4. H. polygyrus-derived antigens increase murine colorectal cancer ( RC) cell migratio and
β-catenin expression. (a) Transwell migration ssay of untr ated control and CT26.WT cells exposed
to 10 µg HES or 10 µg H. pol gyrus antigen for 24 h; (b) Western blot analysis of β-catenin and p38
(loading control) was performed 12- or 18-h fo lowing exposure of CT26. T ce ls to 10 µg HES, 10 µg
H. polygyrus antigen, or an untreated control. Densitometry readings were obtained using ImageJ in
order to determine the changes in protein expression of β-catenin normalised to p38 and expressed as
a fold-change relative to control wells. The data is representative of three (a) and one (b) independent
experiments. Significance was calculated using GraphPad Prism 6.01 and a one-way ANOVA was
performed, where * p < 0.05. Error bars represent the standard error of the mean.
2.5. H. polygyrus-Derived Antigens Influence CRC Cell Migration and β-Catenin Expression in a
Species-Specific Manner
Interestingly, unlike the data obtained for the murine CT26.WT cells, transwell migration assay
results showed that HES and H. polygyrus antigen significantly reduced the migration of human
colorectal cancer cells (Figure 5a). Consistent with their inhibitory effect on the migration of HCT116
cells, results from one Western blot experiment suggest that H. polygyrus-derived antigens decreased
β-catenin levels expressed by these cells (Figure 5b). The expression of β-catenin was decreased by
HES and H. polygyrus antigen at 24 h by 0.92 and 0.74-fold, respectively, and to below detectable levels,
at 30 h.
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Figure 5. H. polygyrus-derived antigens decrease human colorectal cancer (CRC) cell igration and
β-catenin expression. (a) Transwell migration assay of HCT116 cells determined at 24 h, follo ing
exposure to 10 µg S, 10 µg . polygyrus antigen, or an untreated control; (b) Western blot analysis of
β-catenin and p38 (loading control) was performed 24- or 30-h following exposure of HCT116 cells to
10 µg HES, 10 µg H. polygyrus antigen, or an untreated control. Densitometry readings were obtained
using ImageJ in order to determine the changes in protein expression of β-catenin normalized to p38
and expressed as a fold-change relative to control wells. The data is representative of three (a) and one
(b) independent experiments. Significance was analyzed using GraphPad Prism 6.01 and a one-way
ANOVA was performed, where *** p < 0.001. Error bars represent the standard error of the mean.
3. Discussion
Although certain helminths have been shown to modulate the host immune response by
promoting immune-regulatory mechanisms, others have been classified as biological carcinogens
and are irrefutable causes of cancer [37,38]. Currently, evidence for how helminth infections and
their associated antigens impact on the risk of cancer development is still emerging. In this study,
we aimed to determine the effect of soil-transmitted helminths (STH) antigen on colorectal cancer
(CRC) cell behavior.
Accumulating reports suggest that helminth infections can exacerbate the initiation of CRC;
however, whether infection or associated helminth antigens impact on CRC development is
still unclear [9,27–29,32,39]. Our results demonstrate that H. polygyrus antigen and H. polygyrus
excretory/secretory products (HES) significantly reduced the in vitro proliferation of murine (CT26.WT)
CRC cells, while HES alone significantly reduced the in vitro proliferation of human (HCT116) CRC
cells. This result supports previous studies with a Trichinella spiralis-derived antigen, which inhibited
the proliferation of human myeloid leukemia and hepatoma cells in vitro, as well as the proliferation
of intestinal cells in vivo [40–42]. However, they are in opposition to one study with the ES products
from the carcinogenic O. viverrini, which increased the proliferation of fibroblasts in vitro [41].
The mechanism for how H. polygyrus-derived antigens reduced CRC proliferation is unclear;
however, BrdU incorporation and MTT assays demonstrated that HES significantly reduced DNA
synthesis and cell viability, respectively, in CT26.WT cells. These data suggest that the excretory/secretory
antigens are able to shift CRC cells from proliferation to a more quiescent phenotype. This is in
accordance with the findings using Trichinella spiralis-derived antigen, which arrested cancer cell lines
at G1 or S phase of the cell cycle [41]. Interestingly, we found that H. polygyrus antigen did not have
a profound impact on CT26.WT DNA synthesis or cell viability of CRC cells, despite a significant
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impact on cancer cell proliferation. H. polygyrus-derived antigens contain different mixtures of proteins
and glycoproteins, as well as small RNAs, all of which can modulate host cell behavior [6,43–45].
Further analysis of the individual components of H. polygyrus adult antigen and HES would need to be
undertaken in order to determine whether the presence of varying components may account for the
contrasting effects of these antigens on differing aspects of cell proliferation.
Western blot analyses showed that a significant reduction in proliferation of human and murine
CRC cells, following exposure to H. polygyrus-derived antigens, was associated with an upregulation
of p53 and p21 expression; molecules that are associated with increased cell cycle arrest and apoptosis.
Chronic infection with Taenia crassiceps and Trichinella spiralis differentially regulated local expression
of p53 in vivo, whereas exposure of hepatic stellate cells to Schistosoma japonicum soluble egg antigen
induced apoptosis following upregulation of p53 [46–48]. In the latter publication, Schistosoma
japonicum soluble egg antigen induction of apoptosis was associated with inhibition of Akt signaling
and subsequent upregulation of p53-dependent DR5 expression. HES has previously been described as
anti-apoptotic because it significantly reduced annexin V and propidium iodine staining in proliferating
CD4+ T cells [49]. Given our findings, decreased proliferation of CRC cells, following exposure to
HES, is more likely to represent an increase in cell cycle arrest (quiescence) than increased apoptosis of
these cells.
Surprisingly, H. polygyrus antigen and HES caused an increase in CT26.WT cell migration,
which was supported by changes in β-catenin expression. β-catenin (NCBI Gene ID: 1499) forms
part of the adherens junctions between cells and is negatively regulated by adenomatous polyposis
coli (APC) [50]. Significantly, 85% of CRC cancers are associated with mutations in the APC gene,
resulting in a loss of its tumor suppressor function [50,51]. As a result, β-catenin expression becomes
upregulated and acts as an oncoprotein. This activation of the Wnt signaling pathway, of which APC
and β-catenin are a part, has been implicated in initiating CRC development and is associated with poor
prognosis [7,50,52]. It is thus anticipated that the elevated level of expression of β-catenin in treated
CT26.WT cells coincides with a significant increase in cell migration. Importantly, live infection and
in vivo and in vitro treatments with helminth-derived antigens, have previously been shown to alter
the expression of epithelial-mesenchymal transition (EMT) markers, including β-catenin [7,10,53,54].
In contrast to results observed for the murine CT26.WT cell line, H. polygyrus-derived antigens caused
a significant decrease in human HCT116 cell migration, which corresponded with a decrease in
β-catenin expression.
While it is possible that multiple components of H. polygyrus-derived antigens may alter cancer cell
behavior in a number of ways, proteomics analysis of these antigens, combined with sequencing of the
H. polygyrus genome, has led to the identification of several immunomodulatory molecules, including a
structurally distinct equivalent of the mammalian transforming growth factor (TGF)-β cytokine, termed
H. polygyrus TGF-β Mimic (Hp-TGM) [49,55]. Studies with TGF-β demonstrate that signaling induced
by this molecule increased growth arrest and p53 and p21 expression [56], which leads us to hypothesize
that the TGF-β mimic present in H. polygyrus-derived antigens, may drive the changes in cancer cell
behavior that we report here through a common signaling pathway. Interestingly, although SEA was
previously shown to inhibit CD4+ T cell proliferation and amplify TGF-β signaling [57], we found that
the proliferation of CT26.WT cells was not affected by treatment with this antigen. This disparity may
result due to the mechanism of action of the differing antigens; HES and Hp-TGM were reported to
directly bind to TGF-β receptors and phosphorylate Smad, whereas SEA induced TGF-β expression
and increased surface-bound TGF-β on CD4+ T cells [49,55,57]. Intriguingly, our results demonstrate
that migration of human HCT116 cells decreased following exposure to H. polygyrus-derived antigens,
which contrasted with increased migration seen in antigen-exposed murine CT26.WT cells. Analysis of
human HCT116 CRC cells demonstrated that they have a mutated type II TGF-β receptor gene and
cannot respond to TGF-β in order to undergo EMT, invasion, or migration [58]. A subsequent study
demonstrated that HCT116 phosphorylated Smad in response to TGF-β but that this did not alter
proliferation in these cells [59]. It is therefore conceivable that HCT116 cells are less responsive to
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the migration promoting effects of H. polygyrus-derived antigens and the TGF-β mimic contained
within HES.
Our data provides the first evidence that antigen derived from H. polygyrus can alter human and
murine CRC cell behavior. Further work would be required to test our hypothesis that Hp-TGM
orchestrates this effect. This data provides an important basis for determining how parasite antigens
influence cancer cell development in vivo and may have important implications for the etiology of
colorectal cancer within parasite-endemic regions.
4. Materials and Methods
4.1. Heligmosomoides Polygyrus Antigen and HES Preparation
H. polygyrus somatic antigen (referred to as H. polygyrus antigen) and H. polygyrus excretory/secretory
products (HES) were prepared using established methods described by Hewitson et al. and
Johnston et al. [43,60]. In brief, male, 8-week-old, C57BL/6 mice were infected with 400 L3 H. polygyrus
larvae by gavage, and adult worms were recovered 14 days post-infection. Adult worms were washed
extensively before incubation in RPMI 1640 medium, supplemented with 2 mM L-glutamine, 100 U/mL
penicillin, 100 U/mL streptomycin, and 100µg/mL gentamicin. Pooled culture supernatants were filtrated
into phosphate buffered saline PBS over a 3000 MW Amicon membrane (Merck Millipore, Darmstadt,
Germany). The resulting HES was a well characterized preparation containing 374 proteins, novel
O-linked glycoproteins, and small RNAs [43,45,61]. H. polygyrus antigen was prepared by uniformly
homogenizing adult worms in PBS on ice using a Polytron homogenizer (Kinematica AG, Lucerne,
Switzerland; 3 × 30 s pulses at speed 3, with 30 s intervals). The resulting mixture of 446 proteins
was centrifuged at 13,000 g for 30 min, from which the supernatant was collected [43]. The protein
concentration of HES and H. polygyrus antigen was quantified using a NanoDrop 1000 Spectrophotometer
(Thermo Fisher Scientific, Wilmington, USA) before storing at −80 ◦C.
4.2. Cell Culture
The colorectal cancer (CRC) cell line CT26.WT (a murine N-nitroso-N-methylurethane
(NNMU)-induced, undifferentiated fibroblast colon carcinoma cell line) and HCT116 (a human
epithelial colon carcinoma cell line) were purchased from the American Type Culture Collection
(ATCC). CT26.WT and HCT116 were maintained in complete RPMI 1640 and McCoy’s 5A modified
medium, respectively, supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U/mL
penicillin, and 100 U/mL streptomycin. Cells were maintained at 37 ◦C in an atmosphere of 5% CO2
and 95% humidity.
4.3. Growth Curve Assay
The short-term growth of cells was monitored over a 3-day period, as previously described [62],
and 5 × 104 cells were seeded per well, in triplicate, in a 24-well plate. Additionally, HES (10 µg),
H. polygyrus antigen (10 µg), or 1× PBS was added to each of the required wells at the time of seeding.
Live cells were grown in complete culture media and counted 24-, 48- and 72-h post-treatment using
trypan blue exclusion.
4.4. 3-(4,5-dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) Assay
CRC mitochondrial activity was determined using MTT assays (Roche, Mannheim, Germany),
and 8 × 103 cells were seeded per well, in quadruplicate, in a 96-well plate. Additionally, HES (10 µg),
H. polygyrus antigen (10 µg), or 1× PBS was added to each of the required wells for 24 h. A total of
0.5 mg/mL of MTT reagent was added to each well for 4 h, followed by the addition of 100 µL of
solubilization solution. After an overnight incubation, the absorbance reading of each well was read at
a wavelength of 595 nm. The absorbance of medium-only wells was subtracted from the absorbance of
sample wells to obtain a final absorbance reading.
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4.5. Bromodeoxyuridine (BrdU) Incorporation Assay
A BrdU incorporation assay was used in order to determine the effect of HES and H. polygyrus
antigen on CT26.WT DNA synthesis and cell division, and 2 × 105 cells were seeded on a sterile
glass coverslip in a 35 mm dish, treated with HES (10 µg), H. polygyrus antigen (10 µg), or 1X PBS,
and allowed to adhere overnight. A total of 10 µm BrdU (Sigma-Aldrich, Saint Louis, USA) was added
to the medium for 8 h, followed by fixation with Carnoy’s fixative for 20 min at −20 ◦C. Cells were
incubated in 2 M HCl for 1 h at 37 ◦C, neutralized in 0.1 M pH 8.5 borate buffer, and washed with
PBS/0.5% Tween20. Cells were then incubated for 30 min at 37 ◦C in blocking buffer (5% sheep serum in
PBS/0.5% Tween20). BrdU was detected with a mouse monoclonal anti-BrdU (clone: BMC9318, Roche,
Mannheim, Germany) for 30 min at 37 ◦C, followed by a secondary IgG coupled to Alexa488 (RRID:
AB_2534069, Thermo Fisher Scientific, Wilmington, USA) for 30 min at 37 ◦C. Cells were washed
with PBS/0.5% Tween20, incubated in 1 µg 4’6-diamidino-2-phenylindole (DAPI) (Molecular Probes,
Inc, Eugene, USA) for 10 min at room temperature, in the dark, and washed with PBS/0.5% Tween20.
The coverslips were then mounted onto microscope slides, stored in the dark in a humidifying chamber
overnight at 4 ◦C, and visualized by fluorescence microscopy using an Axio Vert.A1 Fluorescent
microscope (Zeiss, Jena, Germany).
4.6. Schistosoma Mansoni Egg Antigen (SEA) Preparation
SEA was kindly gifted by Associate Professor Benjamin Dewals (University of Liège). Briefly,
the livers of Naval Medical Research Institute (NMRI) mice infected with 200 cercariae were cut into
pieces and individually incubated overnight in 20 mL of PBS 100 µg/mL collagenase IV. In order to
collect the egg pellet, the homogenates were filtered and the suspension on top of the final 45 µm
strainer was collected and centrifuged at 1400 rpm for 5 min at 20 ◦C. This was then centrifuged through
a 20% Percoll solution, washed in PBS 1 mM EGTA/1 mM EDTA, and centrifuged through a 25% Percoll
solution, and a further wash in PBS 1 mM EGTA/1mM EDTA was performed. The purified eggs were
resuspended in PBS at a concentration of 100,000 eggs/mL before homogenizing on ice. The crude
mixture was centrifuged at 2000× g for 20 min at 4 ◦C and the supernatant was then ultracentrifuged
at 100,000× g for 90 min and sterilized through a 0.2 µm filter, before protein concentration determined
by bicinchoninic acid (BCA) assay. The final preparation was stored at −70 ◦C.
4.7. Transwell Migration Assay
An established transwell migration assay, utilizing 24-well hanging inserts, fitted with an 8 µm
pore size membrane (Merck Millipore, Darmstadt, Germany), was used to investigate CRC cell
migration [62]. Additionally, 1 × 105 serum starved cells were seeded in triplicate in media containing
1% FBS, onto the apical surface of each hanging insert, and placed into wells containing 10% FBS.
Following treatment with HES (10 µg), H. polygyrus antigen (10 µg), or 1× PBS, the plates were
incubated for 24 h. Post-incubation, the lower surface of the insert was fixed with methanol and stained
with crystal violet. Excess crystal violet was washed off the insert using distilled water before release
of the crystal violet stain into 50% acetic acid. The absorbance of this solution was then quantified at
595 nm using a Rayto RT-2100C Microplate Reader (Rayto, Shenzhen, China).
4.8. Western blotting
Western blotting was performed as previously described [63]. Primary antibodies used were as
follows: mouse monoclonal anti-p21 (clone F-5, Santa Cruz Biotechnology, Inc), mouse monoclonal
anti-p53 (clone DO-1, Santa Cruz Biotechnology, Inc, Texas, USA), mouse monoclonal β-catenin
(clone 15B8, ThermoFisher Scientific, Wilmington, USA), and rabbit polyclonal anti-p38 MAP Kinase
(Sigma-Aldrich, Saint Louis, USA). Signal was detected using peroxidase-conjugated goat anti-mouse
or anti-rabbit antibodies (1:5000) and visualized by enhanced chemiluminescence (ECL) (Thermo
Scientific, Carlsbad, USA or Advansta, R-03031-D25, San Jose, USA). Densitometry readings were
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obtained using ImageJ in order to determine changes in protein expression normalized to p38 (loading
control) and expressed as a fold-change relative to control wells.
4.9. Ethics
Dispensation to perform research at the Institute of Infectious Disease and Molecular Medicine,
Faculty of Health Sciences, University of Cape Town, was granted on 19 October 2015 by the
South African Department of Agriculture, Forestry, and Fisheries, in terms of Section 20 of the Animal
diseases act, 1984 (Act no. 35 of 1984): reference 12/11/17 under the title of research: “Worm power:
Can helminths modify the development of colorectal cancer? AEC 015/001”. Approval for all animal
procedures was given on 18 March 2015 by the Faculty of Health Science Animal Ethics Committee
(Project 015/001) and was performed by researchers accredited by the South African Veterinary
Council (AR15/13922).
4.10. Statistics
Data were assessed for normality and equal variance using the GraphPad Prism software (La Jolla,
CA, USA). For comparison between the three treatment groups, a parametric one-way analysis of
variance with Tukey’s multiple comparison or a nonparametric Kruskal–Wallis with Dunn’s multiple
comparison was used. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Supplementary Materials: Supplementary Materials can be found at http://www.mdpi.com/1422-0067/21/21/
7845/s1. Figure S1: H. polygyrus-derived antigens increase the expression of colorectal cancer (CRC) cell-cycle
arrest proteins p53 and p21.
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